Page results
-
John McGrath is a newly appointed governor as a stakeholder member from North Central London Clinical Commissioning Group (CCG). He is a local GP and has lived and worked in Islington for the last decade in a number of different settings, including multiple GP surgeries as a salaried doctor, local A&E departments and urgent care.
-
What to expect from your neuro-oncology Clinical Nurse Specialist (key worker) at the NHNN
-
Researchers at UCLH and Imperial College Healthcare NHS Trust are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.
-
On Sunday 23 November, the Royal National Orthopaedic Hospital (RNOH) successfully connected to UCLH’s Epic electronic health record (EHR). This is another milestone in our collaboration and digital transformation across North Central London.
-
Our mass vaccination centre at Bidborough House, which we have operated in partnership with UCL, closes on Friday 22 July.
-
Sarah, Duchess of York, and Their Royal Highnesses Princess Beatrice and Princess Eugenie met with staff and young people in a video call to formally open the specialist haematology ward for young adults in the University College Hospital Grafton Way Building last week (Monday 11 July).
-
This page is designed to help parents/carers understand the process and what to expect during their child’s admission to the Paediatric ward.
-
Information about the Integrated Cancer Care Service for children and young adults at the RLHIM.
-
Information about the Integrated Women's Service at the RLHIM patient information leaflet
-
The UCLH Macmillan Support and Information Service Coffee Morning — a welcoming space for anyone affected by cancer or blood conditions to connect, share experiences, and find support.
File results
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications
-
FOI/2022/0223 - Policies/ procedures for management of patients with chest pain
-
FOI/2022/0224 - Procurement for physiotherapy, occupational therapy, pharmacy, radiography, speech and language therapy and sterile services